Ohio State researchers say a CRISPR vaccine beat leishmaniasis in animals as U.S. clinicians report rising cases. The team is preparing human trials.

Novartis agreed to buy Myricx Bio for up to $1.5 billion, adding a novel ADC payload platform and underscoring the Boston‑area connections between small biotech and big pharma. The deal could reshape local hiring and partnership flows as programs move toward clinical development.

UGA researchers found pot marigold petals contain roughly 9% protein and functional traits that could make them useful as binders and emulsifiers in plant-based foods.